Research Article
BibTex RIS Cite

Efficacy of adding intranasal calcitonin to estrogen treatment in postmenopausal osteoporosis

Year 1995, Volume: 8 Issue: 1, 15 - 17, 11.01.1995

Abstract

The purpose of the present study is to investigate the efficacy of adding intranasal calcitonin to estrogen replacement therapy on bone mass density in postmenopausal osteoporosis. Twenty posmenopausal women were randomized to receive either 100IU intranasal salmon calcitonin in addition to 0.625 mg conjugated estrogens and 2.5 mg medroxyprogesterone acetate or 0.625 mg conjugated estrogens and 2.5 mg medroxyprogesterone acetate alone. Women were assessed at 6 months for bone mass density at lumbar spine and femur neck. Both treatment groups not only stopped further bone loss, but had a small increase in bone mass density at the end of 6 months of treatment. In conclusion it appears that adding calcitonin to estrogen treatment in postmenopausal patients does not have an additive effect in inreasing bone mass density. However intranasal calcitonin, may be an alternative in patients suffering from pain due to postmenopausal osteoporosis.

References

  • Lindsay R, Cosman F. Epidemiology of osteoporosis. In: Drife JO, Studd JWW, eds. fIRT and Osteoporosis. London: Springer Verlag, 1990:75- 85.
Year 1995, Volume: 8 Issue: 1, 15 - 17, 11.01.1995

Abstract

References

  • Lindsay R, Cosman F. Epidemiology of osteoporosis. In: Drife JO, Studd JWW, eds. fIRT and Osteoporosis. London: Springer Verlag, 1990:75- 85.
There are 1 citations in total.

Details

Subjects Clinical Sciences
Journal Section Review Makaleler
Authors

M. Dai This is me

M. Erenus This is me

F. Durmuşoğlu This is me

T. Esemenli This is me

S. Pekin This is me

Publication Date January 11, 1995
Published in Issue Year 1995 Volume: 8 Issue: 1

Cite

APA Dai, M., Erenus, M., Durmuşoğlu, F., Esemenli, T., et al. (1995). Efficacy of adding intranasal calcitonin to estrogen treatment in postmenopausal osteoporosis. Marmara Medical Journal, 8(1), 15-17.
AMA Dai M, Erenus M, Durmuşoğlu F, Esemenli T, Pekin S. Efficacy of adding intranasal calcitonin to estrogen treatment in postmenopausal osteoporosis. Marmara Med J. January 1995;8(1):15-17.
Chicago Dai, M., M. Erenus, F. Durmuşoğlu, T. Esemenli, and S. Pekin. “Efficacy of Adding Intranasal Calcitonin to Estrogen Treatment in Postmenopausal Osteoporosis”. Marmara Medical Journal 8, no. 1 (January 1995): 15-17.
EndNote Dai M, Erenus M, Durmuşoğlu F, Esemenli T, Pekin S (January 1, 1995) Efficacy of adding intranasal calcitonin to estrogen treatment in postmenopausal osteoporosis. Marmara Medical Journal 8 1 15–17.
IEEE M. Dai, M. Erenus, F. Durmuşoğlu, T. Esemenli, and S. Pekin, “Efficacy of adding intranasal calcitonin to estrogen treatment in postmenopausal osteoporosis”, Marmara Med J, vol. 8, no. 1, pp. 15–17, 1995.
ISNAD Dai, M. et al. “Efficacy of Adding Intranasal Calcitonin to Estrogen Treatment in Postmenopausal Osteoporosis”. Marmara Medical Journal 8/1 (January 1995), 15-17.
JAMA Dai M, Erenus M, Durmuşoğlu F, Esemenli T, Pekin S. Efficacy of adding intranasal calcitonin to estrogen treatment in postmenopausal osteoporosis. Marmara Med J. 1995;8:15–17.
MLA Dai, M. et al. “Efficacy of Adding Intranasal Calcitonin to Estrogen Treatment in Postmenopausal Osteoporosis”. Marmara Medical Journal, vol. 8, no. 1, 1995, pp. 15-17.
Vancouver Dai M, Erenus M, Durmuşoğlu F, Esemenli T, Pekin S. Efficacy of adding intranasal calcitonin to estrogen treatment in postmenopausal osteoporosis. Marmara Med J. 1995;8(1):15-7.